Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Amarantus Bioscience Holdings (AMBS) Message Board

I read an email Gerald sent to JP back in late Sep

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 30070
Posted On: 03/11/2015 6:59:04 PM
Posted By: Daveludlow
Re: Warp #17998
I read an email Gerald sent to JP back in late September 2014 plainly telling him that as soon as we got the LP002 LymPro data something more "concrete" could be done regarding the partnership. That came and went and nothing "concrete" happened to increase shareholder value.

JP has lost confidence in what Gerald says. Gerald told us all in the Fall of 2014 that we were "on target to up list by year end" and at a much higher stock price! I have not seen the catalysts released that could have done what Gerald forecast would happen. Thus the credibility problem.

I too am disappointed but am hoping that things got delayed and that in the next couple of months catalysts will propel us above .20 cents or more and we can be on our way. To not expect that to happen would be an acknowledgement that you don't place any credence at all in what Gerald has been telling us would happen in the short term.

I don't believe he is a down right liar. I believe he is a smart young man trying to bring about a miracle with a small biotech company. I am willing to overlook some of his "exaggerations" understanding he's been trying to the best he can.

But at some point, we can't do all that AMBS is tying to do on dilution alone. That hurts many shareholders that can't just sit on this for 5 to 10 years. Some of us longs need to see the kind of stock price increases Gerald has been telling us would have happened by now.

I still believe in AMBS, but am weary. I believe JP is in the same boat. We talk maybe once a week by phone. He tells me he still has over 1.8 million shares. He gets mad, I get mad, but in the end we still hold on. That's the truth.



(0)
(0)




Amarantus Bioscience Holdings (AMBS) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us